All News

2058 articles, sorted by publication time.

New Drugs and Clinical Research · us

Reducing Repeat Airway Surgeries: FDA Grants Accelerated Approval to DNA Immunotherapy VOCERYQ

By helping the immune system recognize infected cells, the therapy offers patients with recurrent respiratory papillomatosis a new option to reduce their surgical burden. In a small trial, 7 of 26 patients evaluated for efficacy required no surgery for one year. Whether the effect can be sustained remains a question for confirmatory research.

Cancer and Immunotherapy · global

Selectively Activating T Cells: New Antibody Shows Signs of Efficacy in a Trial of Refractory Solid Tumors

Invikafusp alfa targets two T-cell populations, with 4 of 27 patients in selected dose groups achieving an objective response. This early study offers new clues for addressing treatment challenges after immunotherapy failure, but larger trials are still needed to determine how to identify patients who may benefit and how long the effects may last.